| Literature DB >> 20041048 |
V Changizi1, A Arab Kheradmand, M A Oghabian.
Abstract
Small-angle X-ray scattering (SAXS) is an X-ray diffraction-based technique where a narrow collimated beam of X-rays is focused onto a sample and the scattered X-rays recorded by a detector. The pattern of the scattered X-rays carries information on the molecular structure of the material. As breast cancer is the most widespread cancer in women and differentiation among its tumors is important, this project compared the results of coherent X-ray scattering measurements obtained from benign and malignant breast tissues. The energy-dispersive method with a setup including X-ray tube, primary collimator, sample holder, secondary collimator and high-purity germanium (HpGe) detector was used. One hundred thirty-one breast-tissue samples, including normal, fibrocystic changes and carcinoma, were studied at the 6 degrees scattering angle. Diffraction profiles (corrected scattered intensity versus momentum transfer) of normal, fibrocystic changes and carcinoma were obtained. These profiles showed a few peak positions for adipose (1.15 +/- 0.06 nm(-1)), mixed normal (1.15 +/- 0.06 nm(-1) and 1.4 +/- 0.04 nm(-1)), fibrocystic changes (1.46 +/- 0.05 nm(-1) and 1.74 +/- 0.04 nm(-1)) and carcinoma (1.55 +/- 0.04 nm(-1), 1.73 +/- 0.06 nm(-1), 1.85 +/- 0.05 nm(-1)). We were able to differentiate between normal, fibrocystic changes (benign) and carcinoma (malignant) breast tissues by SAXS. However, we were unable to differentiate between different types of carcinoma.Entities:
Keywords: Breast tumor; coherent scattering; small-angle X-ray scattering
Year: 2008 PMID: 20041048 PMCID: PMC2786093 DOI: 10.4103/0971-6203.39420
Source DB: PubMed Journal: J Med Phys ISSN: 0971-6203
Figure 1Schematic diagram of SAXS setup
Figure 2Coherent X-ray scattering of breast normal tissue (adipose and fibroglandular)
Figure 5Comparison among three coherent scattering spectra of normal, carcinoma and fibrocystic changes
List of 131 breast-tissue samples classified as histological, including information related to peak position
| Carcinoma | 61 | 1.55 ± 0.04 |
| 1.73 ± 0.06 | ||
| 1.85 ± 0.05 | ||
| Fibrocystic | 27 | 1.46 ± 0.05 |
| changes | 1.74 ± 0.04 | |
| Adipose | 10 | 1.15 ± 0.06 |
| Adipose and | 33 | 1.15 ± 0.06 |
| fibroglandular | 1.4 ± 0.04 |
Significance values for the Student's t-test carried out on the peak positions associated with different types of breast disease
| Carcinoma | 61 | 1.55 ± 0.04 | 0.08 | 0.17 | ||
| 1.73 ± 0.06 | ||||||
| 1.85 ± 0.05 | ||||||
| 1.46 ± 0.05 | ||||||
| Fibrocystic changes | 27 | 1.74 ± 0.04 | ||||
| Carcinoma | 61 | 1.55 ± 0.04 | 0.39 | 0.47 | ||
| 1.73 ± 0.06 | ||||||
| 1.85 ± 0.05 | ||||||
| Normal (adipose and | 33 | 1.15 ± 0.06 | ||||
| fibroglandular) | 1.4 ± 0.04 | |||||
| Fibrocystic changes | 27 | 1.46 ± 0.05 | 0.26 | 0.36 | ||
| 1.74 ± 0.04 | ||||||
| Normal (adipose and | 33 | 1.15 ± 0.06 | ||||
| fibroglandular) | 1.4 ± 0.04 | |||||
Significance values for the Student's t-test carried out on the normalized scattering intensity associated with different types of breast disease
| Carcinoma | 61 | 12.1 ± 3.6 | −12.2 | 16.9 | ||
| Fibrocystic changes | 27 | 11.8 ± 4.9 | ||||
| Carcinoma | 61 | 12.1 ± 3.6 | 4.063 | 8.145 | ||
| Normal (adipose and fibroglandular) | 33 | 5.9 ± 0.94 | ||||
| Fibrocystic changes | 27 | 11.8 ± 4.9 | 1.34 | 10.5 | ||
| Normal (adipose and fibroglandular) | 33 | 5.9 ± 0.94 | ||||